Acinic cell carcinoma (AciCC) is a common salivary gland malignancy, typically composed of neoplastic acinic cells with zymogen granules. The vast majority of cases are driven by a t(4;9)(q13;q31) leading to enhancer hijacking and upregulation of the NR4A3 gene. However, a minority of cases do not display NR4A3 overexpression on immunohistochemical examination and are negative for the rearrangement involving the NR4A3 gene when tested by FISH. Such cases overexpress NR4A2, and the protein product is detectable by immunohistochemistry. In this study, we aimed to assess the utility of NR4A2 and NR4A3 immunohistochemistry in the differential diagnosis of salivary gland tumors. Eighty-five cases of classic low-grade ACiCC, as well as 36 cases with high-grade transformation (HGT) and 7 high-grade AciCC cases were included in the analysis. NR4A3 was at least focally positive in 105/128 (82%) cases. Out of the 23 cases that were immunohistochemically negative for NR4A3, 6 displayed nuclear immunopositivity with the NR4A2 antibody. The NR4A3 rearrangement was confirmed by FISH in 38/52 (73%) cases. In addition, this is the first report of an NR4A2 rearrangement being detected by FISH in 2 AciCC cases that were negative for the NR4A3 rearrangement. Our analysis confirms that the majority of AciCC, including high-grade cases and cases with HGT, are immunopositive for NR4A3, and suggests that NR4A3 immunohistochemistry is a powerful tool in the differential diagnosis of salivary gland tumors. However, its utility is limited in sub-optimally fixed samples which often display weaker and focal positivity. Our study also indicates that in a minority of cases, AciCC might be negative for NR4A3 immunostaining, because the pathogenic genetic event in these cases is instead a rearrangement involving the NR4A2 gene.

Biomedical Center Faculty of Medicine in Pilsen Charles University Pilsen Czech Republic

Bioptical Laboratory Ltd Pilsen Czech Republic

Department of Pathology Faculty of Medicine in Pilsen Charles University Pilsen Czech Republic

Department of Pathology Turku University Hospital Turku Finland

Institute of Biomedicine Pathology University of Turku Turku Finland

Medical Laboratory CSD Kiev Ukraine

Zobrazit více v PubMed

WHO classification of tumours editorial board (2022) Head and neck tumours, 5th edn. IARC Press, Lyon, France

Patel NR, Sanghvi S, Khan MN, Husain Q, Baredes S, Eloy JA (2014) Demographic trends and disease-specific survival in salivary acinic cell carcinoma: an analysis of 1129 cases. Laryngoscope 124(1):172–178 PubMed DOI

Xu B, Saliba M, Ho A, Viswanathan K, Alzumaili B, Dogan S, Ghossein R, Katabi N (2022) Head and Neck Acinic Cell Carcinoma: A New Grading System Proposal and Diagnostic Utility of NR4A3 Immunohistochemistry. Am J Surg Pathol 46(7):933–941 PubMed DOI

Thompson LD, Aslam MN, Stall JN, Udager AM, Chiosea S, McHugh JB (2016) Clinicopathologic and immunophenotypic characterization of 25 cases of acinic cell carcinoma with high-grade transformation. Head Neck Pathol 10(2):152–160 PubMed DOI

Skálová A, Sima R, Vanecek T et al (2009) Acinic cell carcinoma with high-grade transformation: a report of 9 cases with immunohistochemical study and analysis of TP53 and HER-2/neu genes. Am J Surg Pathol 33(8):1137–1145 PubMed DOI

Haller F, Bieg M, Will R et al (2019) Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands. Nat Commun 10(1):368 PubMed DOI PMC

Haller F, Skálová A, Ihrler S et al (2019) Nuclear NR4A3 immunostaining is a specific and sensitive novel marker for acinic cell carcinoma of the salivary glands. Am J Surg Pathol 43(9):1264–1272 PubMed DOI

Haller F, Moskalev EA, Kuck S et al (2020) Nuclear NR4A2 (Nurr1) immunostaining is a novel marker for acinic cell carcinoma of the salivary glands lacking the classic NR4A3 (NOR-1) upregulation. Am J Surg Pathol 44(9):1290–1292 PubMed DOI

Wong KS, Mariño-Enriquez A, Hornick JL, Jo VY (2021) NR4A3 Immunohistochemistry reliably discriminates acinic cell carcinoma from mimics. Head Neck Pathol 15(2):425–432 PubMed DOI

Šteiner P, Andreasen S, Grossmann P et al (2018) Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands. Virchows Arch 473(4):471–480 PubMed DOI

Millan N, Tjendra Y, Zuo Y, Jorda M, Garcia-Buitrago M, Velez-Torres JM, Gomez-Fernandez C (2022) Utility of NR4A3 on FNA cytology smears and liquid-based preparations of salivary gland. Cancer Cytopathol. https://doi.org/10.1002/cncy.22632 . Online ahead of print.

Skaugen JM, Seethala RR, Chiosea SI, Landau MS (2021) Evaluation of NR4A3 immunohistochemistry (IHC) and fluorescence in situ hybridization and comparison with DOG1 IHC for FNA diagnosis of acinic cell carcinoma. Cancer Cytopathol 129(2):104–113 PubMed DOI